Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

Abstract

Eplerenone, as compared with placebo, reduced both the risk of death and the risk of hospitalization among patients with systolic heart failure and mild symptoms. (Funded by Pfizer; ClinicalTrials.gov number, NCT00232180.).

Keywords

EplerenoneMedicineHeart failureCardiologyInternal medicineMyocardial infarctionSpironolactoneAldosteroneMineralocorticoidMineralocorticoid receptor

Affiliated Institutions

Related Publications

Aldosterone and antialdosterone therapy in congestive heart failure

Karl T. Weber , Daniel Villarreal

The pathophysiologic cycle that links myocardial failure with the appearance of congestive heart failure is not fully understood. It is clear, however, that an activation of sev...

1993 The American Journal of Cardiology 107 citations

Angiotensin-converting enzyme inhibitor and spironolactone combination therapy

Faïez Zannad

Secondary aldosteronism has deleterious effects in patients with congestive heart failure (CHF) and can contribute to congestion, ventricular arrhythmias, and sudden death. Mort...

1993 The American Journal of Cardiology 38 citations

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Bertram Pitt , Faı̈ez Zannad , Willem J. Remme +5 more

Blockade of aldosterone receptors by spironolactone, in addition to standard therapy, substantially reduces the risk of both morbidity and death among patients with severe heart...

1999 New England Journal of Medicine 8920 citations

Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease

Craig Barr , Chim C. Lang , Jacqueline Hanson +3 more

In chronic heart failure, a diuretic plus an angiotensin-converting enzyme (ACE) inhibitor only partially suppresses aldosterone despite the fact that aldosterone has many harmf...

1995 The American Journal of Cardiology 315 citations

?Escape? of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: Implications for therapy

B. Pitt

Despite the findings in randomized trials of a significant effect of angiotensin-converting enzyme (ACE) inhibitors in reducing morbidity and mortality of patients with symptoma...

1995 Cardiovascular Drugs and Therapy 202 citations

Publication Info

Year: 2010
Type: article
Volume: 364
Issue: 1
Pages: 11-21
Citations: 2924
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2924

OpenAlex

Cite This

APA Style

                            
                                
                                    Faı̈ez Zannad, 
                                
                                    John J.V. McMurray, 
                                
                                    Henry Krum
                                
                                et al.
                            
                            (2010). 
                            Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms. 
                            New England Journal of Medicine
                            , 364
                            (1)
                            , 11-21.
                            https://doi.org/10.1056/nejmoa1009492
                        

Identifiers

DOI: 10.1056/nejmoa1009492